Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints

• Published in: Annals of the rheumatic diseases 1997-09, Vol.56 (9), p.550-557
• Main Authors: Busso, Nathalie, Péclat, Véronique, So, Alexander, Sappino, André-Pascal
• Format: Article
• Language: English
• Subjects: Arthritis, Rheumatoid - enzymology; Binding sites; Biological and medical sciences; Blotting, Northern; Extended Reports; Extracellular matrix; Fibroblasts; Gene expression; Humans; Immunoglobulins; Immunohistochemistry; In Situ Hybridization; Investigative techniques, diagnostic techniques (general aspects); Joint surgery; Medical sciences; osteoarthritis; Osteoarthritis - enzymology; Osteoarticular system. Muscles; Pathogenesis; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; plasminogen activation; Plasminogen Activator Inhibitor 1 - analysis; Plasminogen Activator Inhibitor 1 - genetics; Plasminogen Activators - analysis; Plasminogen Activators - genetics; Proteins; Receptors, Cell Surface - analysis; Receptors, Cell Surface - genetics; Receptors, Urokinase Plasminogen Activator; Rheumatoid arthritis; RNA, Messenger - analysis; Studies; Synovial Membrane - enzymology; Tissue Plasminogen Activator - analysis; Tissue Plasminogen Activator - genetics; urokinase activity; Urokinase-Type Plasminogen Activator - analysis; Urokinase-Type Plasminogen Activator - genetics
• ISSN: 0003-4967; 1468-2060
• DOI: 10.1136/ard.56.9.550

OBJECTIVE To analyse the functional activity of the plasminogen activators urokinase (uPA) and tissue type plasminogen activator (tPA) in human synovial membrane, and to compare the pattern of expression between normal, osteoarthritic, and rheumatoid synovium. The molecular mechanisms underlying differences in PA activities between normal and pathological synovial tissues have been further examined. METHODS Synovial membranes from seven normal (N) subjects, 14 osteoarthritis (OA), and 10 rheumatoid arthritis (RA) patients were analysed for plasminogen activator activity by conventional zymography and in situ zymography on tissue sections. The tissue distribution of uPA, tPA, uPA receptor (uPAR), and plasminogen activator inhibitor type-1 (PAI-1) was studied by immunohistochemistry. uPA, tPA, uPAR, and PAI-1 mRNA values and mRNA distribution were assessed by northern blot and in situ hybridisations respectively. RESULTS All normal and most OA synovial tissues expressed predominantly tPA catalysed proteolytic activity mainly associated to the synovial vasculature. In some OA, tPA activity was expressed together with variable amounts of uPA mediated activity. By contrast, most RA synovial tissues exhibited considerably increased uPA activity over the proliferative lining areas, while tPA activity was reduced when compared with N and OA synovial tissues. This increase in uPA activity was associated with increased levels of uPA antigen and its corresponding mRNA, which were localised over the synovial proliferative lining areas. In addition, in RA tissues, expression of the specific uPA receptor (uPAR) and of the plasminogen activator inhibitor-type 1 (PAI-1) were also increased. CONCLUSION Taken together, these results show an alteration of the PA/plasmin system in RA synovial tissues, resulting in increased uPA catalytic activity that may play a part in tissue destruction in RA.